Pamelor Related Published Studies
Well-designed clinical trials related to Pamelor (Nortriptyline)
Continuation/maintenance treatment with nortriptyline versus combined nortriptyline and ECT in late-life psychotic depression: a two-year randomized study. [2008.06]
Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation: pragmatic randomised controlled trial. [2008.05.31]
Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial. [2007.12]
Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain. [2007.07]
Belief about drug assignment and abstinence in treatment of cigarette smoking using nortriptyline. [2007.04]
Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial--the GONIP Trial. [2006.08]
Postpartum depression: a randomized trial of sertraline versus nortriptyline. [2006.08]
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. [2006.07]
A controlled trial of nortriptyline, sustained-release bupropion and placebo for smoking cessation: preliminary results. [2006]
Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. [2005.10.24]
Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance. [2005.10]
Cost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation. [2005.10]
A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression. [2005.01]
A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation. [2004.11.08]
Extended nortriptyline and psychological treatment for cigarette smoking. [2004.11]
No evidence of increased adverse drug reactions in cytochrome P450 CYP2D6 poor metabolizers treated with fluoxetine or nortriptyline. [2004.01]
Thyroid indices and response to fluoxetine and nortriptyline in major depression. [2003.12]
Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline. [2003.12]
Double-blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression. [2003.10]
A differential response to nortriptyline and fluoxetine in melancholic depression: the importance of age and gender. [2003.07]
Treatment of poststroke generalized anxiety disorder comorbid with poststroke depression: merged analysis of nortriptyline trials. [2003.05]
Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine. [2003.03]
Lithium augmentation of nortriptyline for subjects resistant to multiple antidepressants. [2003.02]
Single-blind comparison of venlafaxine and nortriptyline in elderly major depression. [2003.02]
Effect of nortriptyline and paroxetine on CYP2D6 activity in depressed elderly patients. [2002.10]
Stopping smoking: a prospective, randomized, double-blind study comparing nortriptyline to placebo. [2002.08]
Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy. [2002.07]
Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline. [2002.06]
Effects of nortriptyline and paroxetine on postural sway in depressed elderly patients. [2002.03]
Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on measures of nonlinearity and chaos of heart rate. [2002]
A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression. [2002]
Well-designed clinical trials possibly related to Pamelor (Nortriptyline)
Antidepressant use in nonmajor depression: secondary analysis of a program to encourage active, rewarding lives for seniors (PEARLS), a randomized controlled trial in older adults from 2000 to 2003. [2008.03]
The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial. [2008.03]
Data Management and Design Issues in an Unmasked Randomized Trial of Electroconvulsive Therapy for Relapse Prevention of Severe Depression: The Consortium for Research in Electroconvulsive Therapy Trial. [2007.12]
Efficacy of confrontational counselling for smoking cessation in smokers with previously undiagnosed mild to moderate airflow limitation: study protocol of a randomized controlled trial. [2007.11.15]
Risk factors for and correlates of poststroke depression following discontinuation of antidepressants. [2007.09]
DSM melancholic features are unreliable predictors of ECT response: a CORE publication. [2007.09]
Cerebral volume measurements and subcortical white matter lesions and short-term treatment response in late life depression. [2007.05]
Effect of antidepressant therapy on executive function after stroke. [2007.03]
Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment. [2007.01]
Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). [2006.12]
Aggressive behavior in patients with stroke: association with psychopathology and results of antidepressant treatment on aggression. [2006.06]
[Maintenance electroconvulsive therapy in elderly psychotic unipolar depression] [2006.04.08]
Genetic, developmental and personality correlates of self-mutilation in depressed patients. [2006.03]
Impact of cluster C personality disorders on outcomes of acute and maintenance treatment in late-life depression. [2005.09]
Tryptophan and tyrosine availability and response to antidepressant treatment in major depression. [2005.06]
Reversed diurnal variation in depression: associations with a differential antidepressant response, tryptophan: large neutral amino acid ratio and serotonin transporter polymorphisms. [2005.04]
Weight changes in postpartum women with remitted depression. [2005.03]
Estimating treatment effects from longitudinal clinical trial data with missing values: comparative analyses using different methods. [2004.12.15]
Bipolar II disorder: personality and outcome in two clinical samples. [2004.06]
Identifying depression in the first postpartum year: guidelines for office-based screening and referral. [2004.05]
Role functioning and symptom remission in women with postpartum depression after antidepressant treatment. [2003.12]
Does antidepressant therapy improve cognition in elderly depressed patients? [2003.12]
Good treatment outcomes in late-life depression with comorbid anxiety. [2003.12]
Mortality and poststroke depression: a placebo-controlled trial of antidepressants. [2003.10]
Age may affect response to antidepressants with serotonergic and noradrenergic actions. [2003.09]
Polymorphisms of DRD4 and DRD3 and risk of avoidant and obsessive personality traits and disorders. [2003.07.15]
Occurrence and course of suicidality during short-term treatment of late-life depression. [2003.06]
The relationship of personality disorders to treatment outcome in depressed outpatients. [2003.03]
Serum cholesterol in treatment-resistant depression. [2003]
Psychological intervention and antidepressant treatment in smoking cessation. [2002.10]
Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up. [2002.05]
Other research related to Pamelor (Nortriptyline)
Tako-tsubo syndrome following nortriptyline overdose. [2008.06]
Nortriptyline hydrochloride skin absorption: development of a transdermal patch. [2008.06]
Enhancement of nortriptyline penetration through human epidermis: influence of chemical enhancers and iontophoresis. [2008.04]
Uptake of amitriptyline and nortriptyline with liposomes, proteins, and serum: implications for drug detoxification. [2008.03.01]
Therapeutic drug monitoring of nortriptyline in smoking cessation: a multistudy analysis. [2008.03]
Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands. [2008.01]
Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal. [2007.12]
Fluoxetine and nortriptyline affect NTPDase and 5'-nucleotidase activities in rat blood serum. [2007.09.22]
Chronic orchialgia: consider gabapentin or nortriptyline before considering surgery. [2007.07]
Other possibly related research studies
Antidepressant-Associated Mood Elevations in Bipolar II Disorder Compared With Bipolar I Disorder and Major Depressive Disorder: A Systematic Review and Meta-Analysis. [2008.07.15]
Efficacy of venlafaxine compared with tricyclic antidepressants in depressive disorder: a meta-analysis. [2008.06.26]
Antidepressant therapy in post-stroke depression. [2008.06]
An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy. [2008]
Update on pharmacologic options for smoking cessation treatment. [2008.04]
Use of smoking cessation therapies in individuals with psychiatric illness : an update for prescribers. [2008]
Natural history and treatment of herpes zoster. [2008.01]
Selective serotonin reuptake inhibitors and other antidepressants and risk of fracture. [2008.02]
Assessing free and total morphine following heroin overdose when complicated by the presence of toxic amitriptyline levels. [2007.10]
Safety evaluation of topically applied amitriptyline in porcine full-thickness wounds. [2007.09]
[Pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders] [2007]
Massive intoxication involving unusual high concentration of amitriptyline. [2007.08]
Domestic abuse of the European rave drug prolintane. [2007.09]
WITHDRAWN: Antidepressants for depression in medical illness. [2007.07.18]
Interpreting tricyclic antidepressant measurements in urine in an emergency department setting: comparison of two qualitative point-of-care urine tricyclic antidepressant drug immunoassays with quantitative serum chromatographic analysis. [2007.06]
Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy. [2007.06]
Phase 1A safety assessment of intravenous amitriptyline. [2007.07]
Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. [2007.07]
Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management. [2007]
Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations. [2007.03]
A clinical imperative: assisting patients who smoke to reduce their risk of cardiovascular disease. [2007.03]
Smoking cessation 3: multicomponent interventions. [2007.01]
Use of tricyclic antidepressants in older patients with diabetic peripheral neuropathy. [2007.03]
Antidepressants for smoking cessation. [2007.01.24]
Identifying drugs needing pharmacogenetic monitoring in a Korean hospital. [2007.01.15]
Non-nicotinic therapies for smoking cessation. [2007]
Statistical analysis of longitudinal psychiatric data with dropouts. [2007.12]
Rheological studies on pressure-sensitive silicone adhesives and drug-in-adhesive layers as a means to characterise adhesive performance. [2007.03.21]
Antidepressant therapy in tinnitus. [2007.04]
Emergence, persistence, and resolution of suicidal ideation during treatment of depression in old age. [2007.02]
|
